SCA: Year-end Report 2013

  SCA: Year-end Report 2013

Business Wire

STOCKHOLM, Sweden -- January 29, 2014

Regulatory News:

SCA (STO:SCAA)(STO:SCAB)

JANUARY 1–DECEMBER 31, 2013 (compared with same period a year ago)

· Net sales rose 4% (10% excluding exchange rate effects and divestments) to
SEK 89,019m (85,408)

· Operating profit, excluding items affecting comparability, rose 15% (19%
excluding exchange rate effects and divestments) to SEK 9,934m (8,646)

· Profit before tax, excluding items affecting comparability, rose 21% (25%
excluding exchange rate effects and divestments) to SEK 8,934m (7,382)

· Items affecting comparability totaled SEK -1,251m (-2,634), including
revaluation of Vinda with a positive effect of SEK 564m (0)

· Earnings per share were SEK 7.90 (7.06)

· Cash flow from current operations was SEK 5,989m (7,271)

· The Board of Directors proposes an increase in the dividend by 5.6% to SEK
4.75 (4.50)

(Table included in attached pdf)

http://mb.cision.com/Main/600/9527791/204182.pdf

CEO’S COMMENTS SCA further strengthened its position in emerging markets in
2013. During the fourth quarter of 2013, the offer for the Chinese tissue
company Vinda was completed, and SCA is today the majority owner of Vinda with
51.4% ownership in the company. SCA decided during the year to invest in local
production of hygiene products in India and has launched Libero baby diapers
and Tempo consumer tissue in the Indian market. The efficiency programs in the
hygiene and forest products operations are continuing according to plan.
Consolidated net sales for 2013, excluding exchange rate effects and
divestments, rose 10% compared with a year ago. The increase is mainly
attributable to acquisitions and higher volumes. Operating profit, excluding
items affecting comparability, exchange rate effects and divestments, rose
19%. Cost savings, higher volumes, the acquisition in Europe and gains on
forest swaps contributed to the earnings improvement. Operating profit for
Personal Care and Tissue, excluding items affecting comparability, exchange
rate effects and divestments, rose 4% and 27%, respectively. Operating profit
for Forest Products, excluding items affecting comparability, rose 35%. Profit
before tax, excluding items affecting comparability, exchange rate effects and
divestments, rose 25%. Consolidated net sales for the fourth quarter of 2013,
excluding exchange rate effects and divestments, rose 1% compared with the
same period a year ago. The increase is mainly attributable to higher volumes.
Operating profit, excluding items affecting comparability, exchange rate
effects and divestments, rose 31%. Cost savings and gains on forest swaps
contributed to the earnings improvement. The corresponding profit for Tissue
rose 18%, while profit for Personal Care decreased by 12% as a result of lower
earnings for baby diapers associated with an increase in marketing activities.
However, incontinence care products and feminine care products had a positive
earnings impact. Operating profit for Forest Products, excluding items
affecting comparability, rose 188%. Profit before tax, excluding items
affecting comparability, exchange rate effects and divestments, rose 38%.

NB SCA discloses the information provided herein pursuant to the Securities
Markets Act.

This report has been prepared in both Swedish and English versions. In case of
variations in the content between the two versions, the Swedish version shall
govern. Submitted for publication on January 29, 2014, at 8.00 CET. This
report has not been reviewed by the company’s auditors.

This information was brought to you by Cision http://news.cision.com

Contact:

For further information, please contact:
Johan Karlsson, Vice President Investor Relations, Corporate Communications,
+46 8 788 51 30
or
Boo Ehlin, Vice President Media Relations, Corporate Communications,
+46 8 788 51 36
or
Joséphine Edwall-Björklund, Senior Vice President,
Corporate Communications, +46 8 788 52 34
 
Press spacebar to pause and continue. Press esc to stop.